Ozempic Lawsuit in Illinois (GLP-1 Claims)

What Illinois residents should know

Illinois residents with GLP-1 injury claims are generally not limited to Illinois state court. Most filed cases are transferred into the federal multidistrict litigation, MDL-3094, before Judge Karen S. Marston in the Eastern District of Pennsylvania, which held 3,763 pending cases as of June 1, 2026.

Illinois law still matters: the state's filing deadline, damages rules, and procedural law can shape an individual claim even when the case is litigated in the MDL.

Illinois GLP-1 enforcement and the Ozempic litigation

Illinois residents' federal GLP-1 injury cases are transferred into MDL-3094 in the U.S. District Court for the Eastern District of Pennsylvania for coordinated proceedings. Within the state, the Attorney General has been active on GLP-1 consumer protection: on December 18, 2024, Attorney General Kwame Raoul issued a consumer alert about misleadingly marketed GLP-1 products and sent cease-and-desist letters to five Chicago-area medical spas accused of selling compounded semaglutide as name-brand medication. Illinois also joined a February 2025 letter from more than three dozen state attorneys general urging the FDA to act against counterfeit and illegally compounded GLP-1 drugs.

Sources: Illinois Attorney General — consumer alert on GLP-1 drugs (Dec. 18, 2024); Multistate attorneys general letter to the FDA on GLP-1 drugs (Feb. 19, 2025).

Possible eligibility factors

• Documented use of a GLP-1 medication (prescription and pharmacy records from Illinois providers).
• A diagnosis such as gastroparesis, ileus, or bowel obstruction — commonly supported by a gastric emptying study, endoscopy, imaging, or hospitalization records.
• Injury timing consistent with medication use.
• Filing within the deadline that applies to the claim under Illinois law.

How Illinois claims proceed

Most Illinois GLP-1 cases are filed in or transferred to MDL-3094 in the Eastern District of Pennsylvania for coordinated proceedings. The court has scheduled Rule 702 expert-admissibility hearings for September 10–18, 2026 (Case Management Order No. 32); bellwether trial dates have not yet been set. Illinois's general personal injury limitations period is 2 years (735 ILCS 5/13-202), but accrual and discovery-rule questions are fact-specific for injuries that develop during ongoing medication use.

What records support Ozempic claims in Illinois?

• Prescription, pharmacy, insurance, or provider records showing Ozempic or another GLP-1 medication and dates of use.
• Emergency room, hospital, gastroenterology, imaging, gastric-emptying, surgery, or follow-up records for the alleged injury.
• Records showing diagnosis timing for gastroparesis, bowel obstruction, ileus, aspiration, or related complications.
• Medication history, dose changes, side-effect reports, provider messages, and documents that help connect use and symptoms.

What exposure and legal context matter in Illinois?

Illinois residents may have been prescribed Ozempic, Wegovy, Rybelsus, Saxenda, Mounjaro, Zepbound, or Trulicity through endocrinologists, primary care practices, weight-management clinics, telehealth services, or hospital systems across the state.

Where are Illinois Ozempic cases handled?

Living in Illinois does not necessarily mean the case will be filed only in Illinois. Claims may be evaluated by national firms, filed in federal court, coordinated through MDL proceedings, or handled through another legal process.

Federal courts in Illinois

• Northern District of Illinois
• Central District of Illinois
• Southern District of Illinois

What is the filing deadline for Ozempic lawsuits in Illinois?

For a Illinois resident researching Ozempic claims, the starting point is usually Illinois's general personal injury period: 2 years under 735 ILCS 5/13-202. That is only a starting point, not a final legal deadline for every person.

The real filing deadline can depend on diagnosis date, when the injury and possible cause were discovered, exposure location, wrongful-death issues, prior claim paperwork, and whether the case is filed directly, transferred to an MDL, or handled through another process.

Discovery-rule note: Illinois courts apply a discovery rule in many injury cases, so the clock may run from when the injury and its likely cause were or should have been discovered.

How long do Illinois residents have to file?

Illinois's personal injury statute of limitations applicable to product liability claims is 2 years (735 ILCS 5/13-202). Accrual timing, tolling, and repose periods can still change the real deadline in an individual case.

• Filing period: 2 years — 735 ILCS 5/13-202.
• Discovery rule: Illinois courts apply a discovery rule in many injury cases, so the clock may run from when the injury and its likely cause were or should have been discovered.
• Statute of repose: Product liability actions are also subject to statutory repose periods (735 ILCS 5/13-213).

Because the controlling deadline depends on diagnosis date, discovery facts, exposure history, wrongful-death rules, and how the claim is filed, only a licensed attorney can confirm the deadline that applies to a specific situation. This page is general legal information, not legal advice.

What should Illinois residents ask a lawyer?

• Which GLP-1 medication and injury records do you need for an initial review?
• Do I need a gastric-emptying study, hospitalization record, imaging report, or specialist diagnosis?
• How do the Rule 702 schedule and lack of bellwether trial dates affect current claim review?
• How do state filing deadlines apply to my medication and symptom timeline?
• Would my claim be handled locally, nationally, or through the MDL?
• Are there upfront costs?